E. Budman

Effects of adding a concentrated pomegranate extract to the ration of lactating cows on performance and udder health parameters

M. Nikbachat, A. Zenou, E. Yosef, 2012 .

CNS-accessible Inhibitor of Glucosylceramide Synthase for Substrate Reduction Therapy of Neuronopathic Gaucher Disease

Ying Sun, B. Wang, J. Marshall, 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

Efficacy of Enzyme and Substrate Reduction Therapy with a Novel Antagonist of Glucosylceramide Synthase for Fabry Disease

B. Wang, R. Desnick, R. Scheule, 2015, Molecular medicine.

α-Galactosidase A knockout mice: progressive organ pathology resembles the type 2 later-onset phenotype of Fabry disease.

R. Desnick, K. Ashe, J. Marshall, 2015, The American journal of pathology.

Efficacy of Enzyme and Substrate Reduction Therapy with a Novel Antagonist of Glucosylceramide Synthase for Fabry Disease

B. Wang, R. Desnick, R. Scheule, 2015, Molecular medicine.